Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
about
C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.Graft failure in the modern era of allogeneic hematopoietic SCT.Stem cell Transplantation for Eradication of Minimal PAncreatic Cancer persisting after surgical Excision (STEM PACE Trial, ISRCTN47877138): study protocol for a phase II study.A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice.Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after.Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives.Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques.Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives.Dendritic cells in allogeneic hematopoietic stem cell transplantation.Allogeneic hematopoietic stem-cell transplantation: the next generation of therapy for metastatic renal cell cancer.Order of patient entry influences outcome for metastatic renal cell cancer after non-myeloablative allogeneic stem cell transplantation.Allogeneic stem cell transplantation for patients with metastatic renal cell carcinoma.Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.Review of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in solid tumors excluding breast cancer.The allogeneic graft-versus-cancer effect.Immunotherapy for metastatic colorectal cancer: present status and new options.Achieving graft-versus-tumor effect in brain tumor patients: from autologous progenitor cell transplant to active immunotherapy.NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells.Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCT.Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation.Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis.Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity.Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience.Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.Cytokine expression in tumors treated with donor lymphocyte infusions after allogeneic hematopoietic stem cell transplantation.N-acetyl-L-cysteine increases acute graft-versus-host disease and promotes T-cell-mediated immunity in vitro.Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation.Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinomaAllogeneic stem cell transplantation for renal cell carcinoma
P2860
Q33359498-00886884-2CF9-410D-A313-F78BCD2A0248Q33404733-CA3A0C81-3E1F-4912-A61F-DEFF18680022Q33559203-7227AA9F-3CA4-45B9-8137-FBF2016E9670Q33829731-F828D2B2-363C-49CE-B331-A4D08CF88E39Q35446852-02C7D6A2-751C-4B05-8165-4B130D25894AQ35690761-165EB431-D7AA-466D-A9E1-A78ABD0F00ECQ36114246-9F2D443E-F375-49B6-B053-60FCA5902232Q36114649-54B67758-28EE-4375-9A4A-6D40570017DFQ36272587-A17A3A23-4BF1-4406-9C0E-20954FF01EE7Q36303841-A7072C91-14F4-457A-B37A-E62EDC0D4CF4Q36399856-AE544425-EEA6-4771-8A44-A4A4E71F6270Q36636648-89BD6637-F6C1-478E-ABDE-73AEF42EFE29Q37002020-984375D7-A1F7-4073-8D62-D791FFB78F6DQ37522583-D05B1AFE-A339-4C90-B020-EAE3AAF2C534Q37593125-0359C5DE-7B82-45DF-97BA-87AB1560C867Q37972934-A1334557-76DD-42A1-93DD-69EEFAC5F917Q38063583-8AF1722E-0D30-471B-900E-AB8144BF103EQ40009083-68BDD9D5-A6B8-406F-8ECC-1F2B0FAF591DQ43146785-D8385672-CF19-481A-A55A-1A697825C877Q43430861-E2C2F7D7-708C-46E4-9457-E96CFE5D567DQ44791854-01930EF4-BC03-4B57-9997-5077A4E8B277Q44954461-0125A728-80C4-42C4-9C73-3AB9FC4087B0Q45150263-C81BF1F1-5D36-40D7-8751-1AA608933F32Q45866746-901D21D2-EBAD-42A8-95F7-D6EAD789DC76Q46822195-BEA11A3C-39FF-45E5-A244-3BD2C5F958CFQ47109220-C155E232-01C7-4536-95F1-54ECC8C7A3F9Q50762273-BAB35DED-40D0-4B92-AF71-05CC5C4603D7Q50777164-15AD7833-C729-46C8-8DE6-FBA0630B9F67Q53157308-E074E8D1-B625-4FB4-8F40-EA3725BB2789Q53266395-9E2A149F-30CE-4814-ADE3-B85C6B3EDDE0Q53584539-D0DB3F2B-A19B-4ED5-8CCD-0FB1EE6127D9Q57212292-4C7F8A5A-5EBA-4040-AF43-C2A6C7A2C4EEQ58049115-27D44FF5-B62A-44C3-ABAD-B7DE1AA78DA7
P2860
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Low-intensity conditioning and ...... ith renal and colon carcinoma.
@en
Low-intensity conditioning and ...... ith renal and colon carcinoma.
@nl
type
label
Low-intensity conditioning and ...... ith renal and colon carcinoma.
@en
Low-intensity conditioning and ...... ith renal and colon carcinoma.
@nl
prefLabel
Low-intensity conditioning and ...... ith renal and colon carcinoma.
@en
Low-intensity conditioning and ...... ith renal and colon carcinoma.
@nl
P2093
P2860
P356
P1476
Low-intensity conditioning and ...... ith renal and colon carcinoma.
@en
P2093
Barkholt L
Hentschke P
Remberger M
Söderberg M
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703811
P407
P577
2003-02-01T00:00:00Z